Posttranslational Modifications of RAS Proteins

Area of Science:

• Molecular Biology
• Oncogenesis
• Biochemistry

Background:

• The three human RAS genes encode four proteins critical for cell signaling.
• RAS proteins function as molecular switches regulating growth and differentiation pathways.
• Aberrant RAS signaling is a hallmark of many human cancers, driving oncogenesis.

Purpose of the Study:

• To review the posttranslational modifications (PTMs) of RAS proteins.
• To highlight the enzymes involved in RAS PTMs as potential therapeutic targets.
• To provide a comprehensive overview of RAS PTMs in the context of cancer biology.

Main Methods:

• Literature review of studies on RAS protein modifications.
• Analysis of enzymatic pathways governing RAS PTMs.
• Synthesis of current knowledge on RAS PTMs and their functional consequences.

Main Results:

• RAS proteins undergo diverse PTMs, including farnesylation, geranylgeranylation, palmitoylation, and others.
• These PTMs are essential for RAS membrane localization and effector interactions.
• Specific enzymes catalyzing PTMs represent promising targets for developing anti-RAS therapies.

Conclusions:

• Posttranslational modifications are critical regulators of RAS protein function and signaling.
• Targeting enzymes responsible for RAS PTMs offers a viable strategy for anti-cancer drug development.
• Understanding RAS PTMs is fundamental for advancing oncogenesis research and therapeutic interventions.